Antiviral activity of cathelicidins against porcine epidemic diarrhea virus (PEDV): Mechanisms, and efficacy
Open Access
- 15 November 2024
- journal article
- research article
- Published by Elsevier in Virus Research
- Vol. 350, 199496
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Molecular characterization of cathelicidin in tiger frog (Hoplobatrachus rugulosus): Antimicrobial activity and immunomodulatory activityComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2021
- An in silico scientific basis for LL‐37 as a therapeutic for Covid‐19Proteins: Structure, Function, and Bioinformatics, 2021
- LL-37-mediated activation of host receptors is critical for defense against group A streptococcal infectionCell Reports, 2021
- Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral bindingAntiviral Research, 2021
- Antiviral activity against porcine epidemic diarrhea virus of Pogostemon cablin polysaccharideJournal of Ethnopharmacology, 2020
- Antiviral Peptides: Identification and ValidationInternational Journal of Peptide Research and Therapeutics, 2020
- Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infectionsAntiviral Research, 2019
- Generation, identification, and functional analysis of monoclonal antibodies against porcine epidemic diarrhea virus nucleocapsidApplied Microbiology and Biotechnology, 2019
- Antimicrobial Peptide LL-37 Produced by HSV-2-Infected Keratinocytes Enhances HIV Infection of Langerhans CellsCell Host & Microbe, 2013
- Structural Studies of a Peptide with Immune Modulating and Direct Antimicrobial ActivityChemistry & Biology, 2010